Summary

Global Electroceutical Bioelectric Medicine Market 2024-2028
The electroceutical bioelectric medicine market is forecasted to grow by USD 7774.69 mn during 2023-2028, accelerating AT a CAGR of 6.09% during the forecast period. The report on the electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of neurological disorders, increasing cardiovascular disorders, and increasing fda approval for electroceutical bioelectric medicine.
Technavio's electroceutical bioelectric medicine market is segmented as below:
By Type
• Implantable devices
• Non-invasive devices
By Application
• Arrhythmia
• Epilepsy
• Parkinsons disease
• Tremors
• Others
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing research related to neurological diseases as one of the prime reasons driving the electroceutical bioelectric medicine market growth during the next few years. Also, strengthening R and D on electroceutical bioelectric medicine by vendors and increasing strategic alliances between vendors will lead to sizable demand in the market.
The report on the electroceutical bioelectric medicine market covers the following areas:
• Electroceutical bioelectric medicine market sizing
• Electroceutical bioelectric medicine market forecast
• Electroceutical bioelectric medicine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroceutical bioelectric medicine market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.. Also, the electroceutical bioelectric medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/electroceutical-bioelectric-medicine-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global electroceutical bioelectric medicine market 2018 - 2022
o Exhibit 18: Historic Market Size - Data table on global electroceutical bioelectric medicine market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Implantable devices - Market size and forecast 2023-2028
o Exhibit 34: Chart on Implantable devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Implantable devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Implantable devices - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Implantable devices - Year-over-year growth 2023-2028 (%)
o 6.4 Non-invasive devices - Market size and forecast 2023-2028
o Exhibit 38: Chart on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Non-invasive devices - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Non-invasive devices - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Arrhythmia - Market size and forecast 2023-2028
o Exhibit 48: Chart on Arrhythmia - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Arrhythmia - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Arrhythmia - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Arrhythmia - Year-over-year growth 2023-2028 (%)
o 7.4 Epilepsy - Market size and forecast 2023-2028
o Exhibit 52: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
o 7.5 Parkinsons disease - Market size and forecast 2023-2028
o Exhibit 56: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
o 7.6 Tremors - Market size and forecast 2023-2028
o Exhibit 60: Chart on Tremors - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Tremors - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Tremors - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Tremors - Year-over-year growth 2023-2028 (%)
o 7.7 Others - Market size and forecast 2023-2028
o Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ million)
o Exhibit 69: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share by geography 2023-2028 (%)
o Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 111: Market opportunity by geography ($ million)
o Exhibit 112: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories - Overview
o Exhibit 120: Abbott Laboratories - Business segments
o Exhibit 121: Abbott Laboratories - Key offerings
o Exhibit 122: Abbott Laboratories - Segment focus
o 12.4 ALEVA NEUROTHERAPEUTICS SA
o Exhibit 123: ALEVA NEUROTHERAPEUTICS SA - Overview
o Exhibit 124: ALEVA NEUROTHERAPEUTICS SA - Product / Service
o Exhibit 125: ALEVA NEUROTHERAPEUTICS SA - Key offerings
o 12.5 Bayer AG
o Exhibit 126: Bayer AG - Overview
o Exhibit 127: Bayer AG - Business segments
o Exhibit 128: Bayer AG - Key news
o Exhibit 129: Bayer AG - Key offerings
o Exhibit 130: Bayer AG - Segment focus
o 12.6 Boston Scientific Corporation
o Exhibit 131: Boston Scientific Corporation - Overview
o Exhibit 132: Boston Scientific Corporation - Business segments
o Exhibit 133: Boston Scientific Corporation - Key news
o Exhibit 134: Boston Scientific Corporation - Key offerings
o Exhibit 135: Boston Scientific Corporation - Segment focus
o 12.7 electroCore Inc.
o Exhibit 136: electroCore Inc. - Overview
o Exhibit 137: electroCore Inc. - Product / Service
o Exhibit 138: electroCore Inc. - Key offerings
o 12.8 EndoStim Inc
o Exhibit 139: EndoStim Inc - Overview
o Exhibit 140: EndoStim Inc - Product / Service
o Exhibit 141: EndoStim Inc - Key offerings
o 12.9 LivaNova PLC
o Exhibit 142: LivaNova PLC - Overview
o Exhibit 143: LivaNova PLC - Business segments
o Exhibit 144: LivaNova PLC - Key news
o Exhibit 145: LivaNova PLC - Key offerings
o Exhibit 146: LivaNova PLC - Segment focus
o 12.10 Medtronic
o Exhibit 147: Medtronic - Overview
o Exhibit 148: Medtronic - Business segments
o Exhibit 149: Medtronic - Key news
o Exhibit 150: Medtronic - Key offerings
o Exhibit 151: Medtronic - Segment focus
o 12.11 NeuroMetrix Inc.
o Exhibit 152: NeuroMetrix Inc. - Overview
o Exhibit 153: NeuroMetrix Inc. - Product / Service
o Exhibit 154: NeuroMetrix Inc. - Key offerings
o 12.12 NEURONETICS Inc.
o Exhibit 155: NEURONETICS Inc. - Overview
o Exhibit 156: NEURONETICS Inc. - Product / Service
o Exhibit 157: NEURONETICS Inc. - Key offerings
o 12.13 NeuroPace Inc.
o Exhibit 158: NeuroPace Inc. - Overview
o Exhibit 159: NeuroPace Inc. - Product / Service
o Exhibit 160: NeuroPace Inc. - Key offerings
o 12.14 Nevro Corp.
o Exhibit 161: Nevro Corp. - Overview
o Exhibit 162: Nevro Corp. - Product / Service
o Exhibit 163: Nevro Corp. - Key offerings
o 12.15 Patricia Industries
o Exhibit 164: Patricia Industries - Overview
o Exhibit 165: Patricia Industries - Product / Service
o Exhibit 166: Patricia Industries - Key offerings
o 12.16 Soterix Medical Inc.
o Exhibit 167: Soterix Medical Inc. - Overview
o Exhibit 168: Soterix Medical Inc. - Product / Service
o Exhibit 169: Soterix Medical Inc. - Key offerings
o 12.17 Synapse Biomedical Inc.
o Exhibit 170: Synapse Biomedical Inc. - Overview
o Exhibit 171: Synapse Biomedical Inc. - Product / Service
o Exhibit 172: Synapse Biomedical Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations